Prevention and Application of Pituitrin in vasoplegic syndrome during Aortic Dissection operation:a randomized controlled study

Prevention and Application of Pituitrin in vasoplegic syndrome during Aortic Dissection operation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300067645

Enrollment

Unknown

Registered

2023-01-16

Start date

2023-01-10

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

experimental group:Pituitrin intravenous infusion

control group:Intravenous infusion of normal saline

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Patients aged 18-75 years. 2. Patients undergoing aortic dissection surgery 3. Volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria : 1. Preoperative application of cardiac assist devices (such as IABP, cardiac pacemaker, left ventricular assist device, etc.); 2. Preoperative use of pituitrin 3. Patients need IABP or ECMO support after heart re-beating ; 4. Patients died during the operation; 5. The researchers considered it inappropriate for the subjects to participate in this study.

Design outcomes

Primary

Measure	Time frame
Incidence of Vasoplegia Syndrome;	—

Secondary

Measure	Time frame
vasoactive inotropic score;Blood sodium;blood glucose;Lactate value;Urine output;	—

Countries

China

Contacts

Public ContactSuchun Ding

Yantai Yuhuangding Hospital

dd94207@163.com+86 0535 6691999 81427

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026